| 000 | 01288 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518022829.0 | ||
| 264 | 0 | _c20200525 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1474-4457 | ||
| 024 | 7 |
_a10.1016/S1473-3099(18)30725-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMueller, Judith E | |
| 245 | 0 | 0 |
_aLong-term effectiveness of MenAfriVac. _h[electronic resource] |
| 260 |
_bThe Lancet. Infectious diseases _c03 2019 |
||
| 300 |
_a228-229 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAfrica _xepidemiology |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aBlood Bactericidal Activity |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _xepidemiology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup A _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 19 _gno. 3 _gp. 228-229 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(18)30725-4 _zAvailable from publisher's website |
| 999 |
_c29354008 _d29354008 |
||